Charles M. Doucot - 17 Aug 2023 Form 4 Insider Report for PSYCHEMEDICS CORP (PMDI)

Reporting relationship: Executive Vice President
Issuer ticker: PMDI
Reported as of: 17 Aug 2023
Net transaction value: -$59,182
SEC form: 4
Accepted by SEC: 21 Aug 2023, 17:48:47 UTC
Prior SEC filing: 24 May 2023
Source filing: View source filing
Reporting owner signature: Patrick J. Kinney, Jr., as attorney-in-fact for Charles M. Doucot

Key filing fact

Charles M. Doucot filed Form 4 for PSYCHEMEDICS CORP (PMDI) on 21 Aug 2023.

Key facts

This page summarizes Charles M. Doucot's Form 4 filing for PSYCHEMEDICS CORP (PMDI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Aug 2023, 17:48.

Change

Previous filing in this sequence was filed on 24 May 2023.
Current net transaction value: -$59,182.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMD transaction

Common Stock, $.005 Par Value

Sale

Transaction value: $59,182
Shares: -12,700
Change %: -35%
Price: $4.66
Shares after: 23,250
Date: 17 Aug 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.